Copertina

Medications against drugs: Development of medications to prevent and treat substance use disorders

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	Iván D. Montoya
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Universitat de València 2022
Soggetti:	Comunicación treatment clinical trials Medications development substance use disorders
Accesso online:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5 Acceder al recurso 6
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Consideraciones metodológicas y éticas para la conducción de ensayos clínicos controlados aleatorizados (ECCA) sobre intervenciones para las adicciones
di: Rodrigo Marín-Navarrete
Pubblicazione: (2013)

What are the current clinical guidelines for patients with co-occurring mental health and substance use disorders?
di: Tripdatabase
Pubblicazione: (2026)

Does psychological therapy improve the mental health of people with borderline personality disorder and substance abuse disorder?
di: Marta Macías-Gil
Pubblicazione: (2022)

Summarize evidence on medication management of bipolar disorder with substance use disorder.
di: Tripdatabase
Pubblicazione: (2025)

What is the best treatment option for cocaine addiction cessation?
di: Tripdatabase
Pubblicazione: (2026)

Panic disorder and psychoactive substance use in primary care
di: Andressa Jacondino Pires
Pubblicazione: (2014)

Multicenter Randomized Clinical Trial of Brief Psychotherapy versus Usual Treatment for Common Mental Disorders in Adults
di: Marco A. Luengo-Castro
Pubblicazione: (2025)

Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer’s disease after three months of treatment. An open-label study
di: Luis Felipe José Ravic de Miranda
Pubblicazione: (2013)

Assessment of depressive symptoms in severe smokers with minimal-mild depressive symptomatology receiving pre-smoking abstinence for integrated treatment: a randomized clinical trial
di: A Moreno-Coutiño
Pubblicazione: (2015)

What are the best quality outcome measures for evaluating the effectiveness of substance use treatment programs?
di: Tripdatabase
Pubblicazione: (2026)

BIOETHICS, AUTONOMY, AND SELF-DETERMINATION IN PATIENTS ADMITTED TO A TEACHING HOSPITAL FOR TREATMENT OF SUBSTANCE USE DISORDER
di: Lucas Franca-Garcia
Pubblicazione: (2017)

Effect of cathodal high-voltage electrical stimulation on pain in women with TMD
di: Natalia C. M. C. Gomes
Pubblicazione: (2012)

Are there any Canadian protocols for managing alcohol withdrawal with phenobarbital in hospital?
di: Tripdatabase
Pubblicazione: (2026)

PARENTS’ PERSPECTIVES ABOUT THEIR SONS’ DRUG ADDICTION AND REHABILITATION PROCESS
di: Gladys M. Laboy-García
Pubblicazione: (2016)

Epidemiological profile of patients treated at a psychosocial care center ad III
di: Paula Cândida da Silva Dias
Pubblicazione: (2017)

Misuse of pharmaceuticals by regular psychostimulant users is linked to mental health problems
di: Caroline L. Salom
Pubblicazione: (2017)

Evaluation of mental health and occupational stress in Mexican medical residents
di: Sofía Vidal de la Fuente
Pubblicazione: (2020)

What are non-pharmacological interventions for managing opioid withdrawal?
di: Tripdatabase
Pubblicazione: (2025)

Right to Trial & FDA Upgrade Act
di: Mike P. Sinn
Pubblicazione: (2026)

Development of Social Skills in Female Crack Users: Multiple Case Study
di: Jéssica Limberger
Pubblicazione: (2017)

Post-trial access practices in conducted clinical trials for Malaria, Tuberculosis, and Neglected Tropical Diseases (NTDs) across Sub-Saharan African countries: A quantitative study
di: Seralegne, Yemisrach, et al.
Pubblicazione: (2025)

Post-trial access practices in conducted clinical trials for Malaria, Tuberculosis, and Neglected Tropical Diseases (NTDs) across Sub-Saharan African countries: A quantitative study
di: Seralegne, Yemisrach, et al.
Pubblicazione: (2025)

Non-medical use of methylphenidate: a review
di: Luana Freese
Pubblicazione: (2012)

What are the indications and contraindications for initiating methadone treatment in patients with opioid use disorder?
di: Tripdatabase
Pubblicazione: (2025)

Clinical eHealth
Pubblicazione: (2019)

Current Controlled Trials in Cardiovascular Medicine
Pubblicazione: (2006)

Gates Open Research
Pubblicazione: (2018)

Gambling addiction: myth or reality? Analysing the scientific evidence on gambling disorder.
di: Gemma Mestre-Bach
Pubblicazione: (2022)

Current Therapeutic Research
Pubblicazione: (2015)

Randomised Field Trial for the Performance Diagnostics and Yield Optimisation of Rural Water Treatment Systems in Kenya
di: Mwangi, Wanjiku, et al.
Pubblicazione: (2010)

SYMPTOMS, SIGNS AND STATISTICS. STATISTICS APPLIED TO THE HEALTH AND LIFE SCIENCES
di: Miguel A. Martínez-Beneito
Pubblicazione: (2015)

Explanatory and pragmatic clinical trials Methodological differences
di: CLAUDIA LILIANA VALENCIA-RICO
Pubblicazione: (2023)

Wellcome Open Research
Pubblicazione: (2017)

Genai For Drug Discovery And Development
di: Gopalakrishnan Mahadevan
Pubblicazione: (2025)

Perception of freedom in leisure among substance users and nonusers
di: Diego Eugênio Roquette Godoy Almeida
Pubblicazione: (2018)

Psychiatric symptoms, substance use, and other medical conditions in patients with obesity who seek treatment for weight loss
di: Rodrigo Marín-Navarrete
Pubblicazione: (2016)

Cuba’s National Clinical Trials Coordinating Center: Emergence, Evolution, and Main Results
di: María A. Pascual
Pubblicazione: (2011)

Brazilian Journal of Anesthesiology
Pubblicazione: (2018)

Perception of the informed consent form by participants in clinical trials
di: Silmara Meneguin
Pubblicazione: (2014)

Views on treatment adherence among psychoactive substance-dependent women in the outpatient setting: a qualitative study
di: Dione Viégas Almeida Ribeiro
Pubblicazione: (2012)